Literature DB >> 7841354

Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease.

A Woywodt1, P Neustock, A Kruse, K Schwarting, D Ludwig, E F Stange, H Kirchner.   

Abstract

Etiology and pathogenesis of inflammatory bowel disease (IBD) remain obscure. There is substantial evidence that proinflammatory cytokines such as Interleukin-1 beta (IL-1 beta), Interleukin-6 (IL-6) and Tumour Necrosis Factor-alpha (TNF-alpha) exhibit a key role in the the inflammatory process. In situ hybridisation can depict individual cells producing cytokine mRNA. We performed hybridisation with antisense probes specific for IL-1 beta, IL-6 and TNF-alpha on sections of paraffine-embedded biopsies. Specimens obtained from three control persons and six cases of Crohn's disease (CD) were investigated. Only few positive cells were found in tissue sections of control persons, clusters of lamina propria cells or epithelial cells containing cytokine mRNA were not observed. Inflammatory bowel disease tissue contained large numbers of cells producing mRNA specific for the three proinflammatory cytokines assayed. IL-1 beta, IL-6 and TNF-alpha mRNA were predominantly detected corresponding to cells of the lamina propria. Single cells containing mRNA specific for IL-6 were also found among the epithelial lining of intestinal crypts. Epithelial cells containing IL-1 beta and IL-6 mRNA were found in specimens derived from one patient with Crohn's disease. Notably, large amounts of cells containing cytokine mRNA were not only found in inflamed, but also in macroscopically normal mucosa. In conclusion, using proinflammatory cytokines as a model, we established in situ hybridisation on sections of mucosal biopsies permitting further insight into immune activation at individual cell level.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841354

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  15 in total

1.  Tumour necrosis factor-alpha production stimulated by heat shock protein 70 and its inhibition in circulating dendritic cells and cells eluted from mucosal tissues in Crohn's disease.

Authors:  T Whittall; Y Wang; C G Kelly; R Thompson; J Sanderson; M Lomer; S Y Soon; L A Bergmeier; M Singh; T Lehner
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

2.  Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa.

Authors:  S Shinozaki; T Nakamura; M Iimura; Y Kato; B Iizuka; M Kobayashi; N Hayashi
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice.

Authors:  Y Arai; H Takanashi; H Kitagawa; K J Wirth; I Okayasu
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

4.  Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity.

Authors:  C Schmidt; T Giese; B Ludwig; M Menges; M Schilling; S C Meuer; S Zeuzem; A Stallmach
Journal:  Int J Colorectal Dis       Date:  2005-08-23       Impact factor: 2.571

5.  Tumour necrosis factor-alpha (TNF-alpha) transcription and translation in the CD4+ T cell-transplanted scid mouse model of colitis.

Authors:  A M Williams; C V Whiting; K Bonhagen; J Reimann; S Bregenholt; M H Claesson; P W Bland
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

6.  Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function.

Authors:  S M Fish; R Proujansky; W W Reenstra
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

7.  Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.

Authors:  R Daig; G Rogler; E Aschenbrenner; D Vogl; W Falk; V Gross; J Schölmerich; T Andus
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

8.  Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

Authors:  Nicola Eastaff-Leung; Nicholas Mabarrack; Angela Barbour; Adrian Cummins; Simon Barry
Journal:  J Clin Immunol       Date:  2010-01       Impact factor: 8.317

9.  Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist.

Authors:  Andrew W Stadnyk; Moorix M W Yeung; Sen Rong Yan
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

10.  Factors affecting Caco-2 intestinal epithelial cell interleukin-6 secretion.

Authors:  S J Vitkus; S A Hanifin; D W McGee
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-09       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.